Im going to add the green peppers
June 1, 2026: More Than 125 Lawsuits Join GLP-1 MDL as Eli Lilly Asks for Dismissal of Plaintiffs Experts With the GLP-1 MDL reaching 3,763 total cases as of June 1, Eli Lilly, the manufacturer of Ozempic, has requested that the judge dismiss the plaintiffs experts
9 Research gaps and future priorities 9.1 Reproductive-oriented RCTs: shifting from metabolic surrogates to hard endpoints To date, most GLP-1RA trials in PCOS have been designed around metabolic efficacy (weight change and insulin-resistance/glycaemic indices) as the primary outcomes, with reproductive outcomesovulation, clinical pregnancy, and live birthreported inconsistently and often as secondary or exploratory measures
Be Gentle: Use gentle pressure while massaging
To preserve your hard work and keep your weight steady, you should continue to engage in healthy habits otherwise known as moving into your weight management phase
The same label carries a warning: "There have been rare postmarketing reports of pulmonary aspiration in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation who had residual gastric contents despite reported adherence to preoperative fasting recommendations." That is the whole reason for a pre-surgery pause with GLP-1 medicines
